| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $343.5M | +66.0% |
| Cost of Revenue | $39.8M | +27.5% |
| Gross Profit | $303.8M | +72.9% |
| R&D Expense | $62.4M | +42.1% |
| SG&A Expense | $35.7M | +116.7% |
| Operating Income | $113.5M | +113.0% |
| Pre-tax Income | $114.0M | +97.3% |
| Income Tax | -$40.8M | -639.5% |
| Net Income | $154.8M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.8M | +69.9% |
| Accounts Receivable | $81.1M | +61.1% |
| Current Assets | $904.1M | +331.8% |
| Total Assets | $991.4M | +293.8% |
| Current Liabilities | $111.3M | +9.1% |
| Total Liabilities | $112.8M | +8.9% |
| Stockholders' Equity | $878.6M | +1216.4% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $126.6M | +52.5% |
| Capital Expenditures | $1.9M | +680.4% |
| Investing Cash Flow | -$640.6M | -809.7% |
| Financing Cash Flow | $560.4M | — |
| Free Cash Flow | $124.7M | +50.7% |
| +208.3% |
| EPS (Basic) | $0.82 | +182.8% |
| EPS (Diluted) | $0.70 | +204.3% |